cbdMD reported total net sales of $5.1 million for the three months ended December 31, 2024, a decrease of 4.9% year-over-year. Despite the sales decline, the company achieved a net income of $15,095 and positive Adjusted EBITDA of $214,817. This performance was attributed to optimizing product portfolio, right-sizing cost structure, and investing in marketing, with wholesale sales showing a positive impact and the launch of a new beverage line.
Total net sales decreased by 4.9% year-over-year to $5.1 million, primarily due to a reduction in e-commerce sales.
The company achieved a net income of $15,095 for the quarter, a significant improvement from a net loss in the prior year.
Adjusted EBITDA was positive at $214,817, reflecting the company's focus on profitability and cost controls.
Wholesale sales increased by $0.2 million year-over-year, partially offsetting the decline in e-commerce sales.
cbdMD is focused on achieving profitability and expanding its business in fiscal 2025 and beyond through product innovation, channel expansion, and brand cultivation. The company aims to improve profitability and cash flow, with a focus on cost controls and strategic growth initiatives.
Visualization of income flow from segment revenue to net income